ADM Korea Inc.

ADM Korea Inc. has provided the full scope of service for clinical trials with a vision to be the best clinical service provider in Asia since 2003.

Almac Pharmaceutical Services

Almac Clinical Services is an established, leading CDMO providing Korean biopharmaceutical companies with a holistic solution to their clinical supply chain. Our services range from supply chain management, drug procurement, blinding, primary & secondary packaging, storage, temperature management, distribution and QP services. With regional headquarters in Singapore, Almac support regionally formed trials as well as Asia-Pacific elements of fully global studies.

C&R Research Inc.

C&R Research is Korea's first Full Served CRO established in July 1997. So far, we have about 1600 local and global clinical trial projects experience, including P 1-3 clinical trials for permission, PMS, OS, and P4 clinical trials to drug development consulting, Medical Writing, clinical operation, project management, data management, statistical analysis, CSR writing, etc. We provide it either as an full or as a part of it.

Catalent Pharma Solutions

Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range of services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine CGMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years¡¯ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.

CLIPS BnC Co., Ltd.

CLIPS BnC (Contract Research Organization) provides all services relating to clinical trials for pharmaceuticals, biology, and medical devices in Korea and APEC areas. We have a number of experts that possess rich experience in a variety of treatment areas, and we also have plenty of experience working with regulatory institutions (MFDS, IRB). The customized services of CLIPS BnC CRO deliver excellent experiences as well as extensive full-service and strategic solutions in all treatment fields. Join CLIPS BnC! Contact us: bd@clipsbnc.com


Founded in 2000, DreamCIS, with 2000+ project experience, provides full-scope services including Phase 1-4, rPMS to NIS. DreamCIS enabled to offer more expertise services to customers in DM/Statistics area by establishing Biometrics Center in November 2008 and was chosen ¡®Excellent CRO¡¯ in quality management by KoNECT. After DreamCIS was acquired by Tigermed in 2015, DreamCIS enhanced its global network and became a step closer to global CRO by SOP integration with Tigermed. Especially, DreamCIS accumulated more global clinical trials experience by participating in multi-national and global projects. Through constant brand value creation in clinical trials, DreamCIS has reinforced its presence as Korea¡¯s TOP CRO by listing on KOSDAQ market as the industry¡¯s first and winning ¡®National Industry Awards¡¯ for two consecutive years in 2020 and 2021.


Dt&SanoMedics considers it a great privilege to change people¡¯s lives into better lives together with clients. Dt&SanoMedics hopes to grow into a CRO that brings the best results. Our study team will complete a risk analysis at project starting stage and after reviewing, we prepare a countermeasure for budgeting and project planning. Then we suggest Maximum and Minimum cost based on planned clinical development and market access strategy. After design discussion, we do internal meeting with each team in charge and reflect on all factors that should be considered in early page in the protocol design and project management plan. Our management teams will communicate with each other continuously through regular meetings for transparency. And based on planned timeline, market objectives and budget that a client can have, we plan clinical design and reflect on the budget. Collaboration is key to Dt&SanoMedics¡¯s successful relationships with our clients. Our team will encourage a constant exchange of ideas, joint strategy, and common goals.

GCCL Co., Ltd.

GCCL is a GCLP based company that provides full-stage clinical sample analysis services from phase 1 PK/PD analysis to phase 4. From 2011, we have participated in more than 750 clinical trial projects with overall analysis such as 1) new drug development, 2) investigator studies, 3) medical devices, 4) health functional food clinical trials, etc.


IQVIA is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence¢â delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 72,000+ employees, IQVIA conducts operations in more than 100 countries.

Korean Cancer Study Group

Korean Cancer Study Group (KCSG) is the nation¡¯s leader in multi-institutional clinical trials for cancer treatment. KCSG has been dedicated to advance clinical and translational cancer research through multi-institutional clinical trials in Korea since its establishment in 1998. In addition, KCSG has about 850 members including most oncologists from 110 institutions or hospitals in Korea and provides education and training on cutting-edge knowledge in cancer treatment and clinical trials. As one of departments in KCSG, Clinical Research Operational Center has about 50 staff whom work functions for full scopes like CRO provide high-quality clinical operational services to any study sponsors both investigator and company, complying with ICH guidelines, Korean GCP, and relevant regulations.

LSK Global Pharma Service Co., Ltd.

LSK Global Pharma Service Co., Ltd. is the largest One Stop Full Service contract research organization (CRO) in Korea. We provide services of a variety of therapeutic areas including oncology, cardiovascular, endocrinology, and etc. Through various global clinical trial opportunities, we have developed partnerships with many local and overseas pharmaceutical companies as well as global CROs and we have equipped ourselves with abilities to provide ¡®One-Stop Total Solution¡¯ for new drug development and clinical trials. In abstract, with improved cost effectiveness, our accumulated know-how, expertise, and effective risk management we bring client satisfaction when conducting a successful clinical trial in Korea. We have successfully established a stable global standard clinical trial management system over 20 years with our experience, capability of designing and operating clinical trials.

Marken Korea

Marken is a wholly owned subsidiary of UPS. Marken offers a state-of-the-art GMP-compliant depot network and logistic hubs for clinical drug product storage and distribution in 58 locations worldwide, while maintaining the leading position for Direct-to-Patient and Home Healthcare services, biological sample shipments and biological kit production. Marken¡¯s dedicated team manage 110,000 drug product and biological sample shipments every month at all temperature ranges in more than 220 countries. Additional services such as ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken¡¯s unique position in the pharma and logistics industry.

Medi Help Line Co., Ltd.

Medi Help Line is currently providing a ¡®Real Total Package Solution¡¯ from the R&D Strategy Consulting Service to the Outsourcing Services including IND/NDA, Medical Writing, Clinical Operation, Data Management, Biostatistics, Pharmacovigilance, Quality Assurance, Post-NDA, HIRA listing, etc.

Oracle Health Sciences

As a leader in Life Sciences cloud technology, Oracle Health Sciences¡¯ Clinical One and Safety One are trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance. With over 20 years¡¯ experience, Oracle Health Sciences is committed to supporting clinical development, delivering innovation to accelerate advancements, and empowering the Life Sciences industry to improve patient outcomes.


RWS (Merged with SDL) is the world's largest language service provider and the leader in translation for life sciences. We work with 19 of the top 20 pharma companies and 8 of the top 10 CROs. In Korea, we¡¯ve helped to translate IND, NDA, MAA, GMP, PMS, IP, and Marketing materials for 150 life sciences companies for 1994.

SCL Healthcare

SCL Healthcare has capacity to expand globally with Central Laboratory Service for Clinical trials, Companion Biomarker and Bio-Logistics.

Seoul National University Hospital Clinical Trials Center

Seoul National University Hospital Clinical Trials Center (SNUH CTC) was established in 1995 with the vision of becoming the world¡¯s leading early clinical trials center. Since its establishment, SNUH CTC has been leading the development of clinical trials in Korea, contributing to establish Seoul National University Hospital as a world-class research center. In particular, SNUH CTC was designated as the first regional clinical trials center and the Global Center of Excellence in Early Clinical Trials by the Ministry of Health and Welfare, the Republic of Korea in 2004 and 2012. In addition, the annual number of conducted clinical trials is on par with global hospitals. SNUH CTC will continue to carry out top-notch clinical trials research and to function as an indispensable institution for global drug development.

Synex Consulting Ltd.

Synex is a Full-Service CRO to help you conduct clinical trials in Korea. Our Multidisciplinary expert team will answer your questions clearly about not only for IND approval, investigator recruitment, site selection, IP importation and management but also CMO arrangement, NDA approval, reimbursement listing and market research, etc. Synex can arrange ample opportunities for you to meet MFDS reviewers face to face even before submission of IND application and you can have substantial feedbacks more comfortable.

Trial Informatics

Data Science Company for data-driven analytics with clinical insight and digital health technology! Trial Informatics is a spin-off company from Asan Medical Center in Korea. We provide precision digital data platforms (imaging, pathology & genetic), real-time data exploration, and consulting for various clinical trials. Trial Informatics is also organized with top-class IT engineers, data scientists, clinical trial experts, and clinicians in therapeutic fields (radiologists & oncologists). We are also certified by ISO 9001, Good Software, and multiple audits. OncoTrial Board is a web-based solution optimized for clinical trial data with web-PACS and analytic visualization. Using this solution, medical monitoring of each subject can be performed through a graphical summary anywhere and anytime! Once the clinical trial is completed, pharmaceutical companies reutilize the accumulated data in OTB solution for a further clinical trial or new drug development. We also provide medical affairs services with clinical experts, including consulting, exploratory statistical analysis, and scientific publications.


Veeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,100 customers, ranging from the world¡¯s largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, Veeva is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

Xcell Therapeutics Inc.

Xcell Therapeutics is the only cell culture media manufacturer in Korea to achieve chemically defined media for hMSC. In the developing bio-industry, the importance of the media is becoming greater than ever. Xcell Therapeutics has worked long years of research to develop cell culture media technology for the next upcoming future regenerative bio industry. With our technology, we aim to commit to mankind and our nature.